Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afrezza PK and Safety in Pediatric T1DM
NCT02527265Phase 2Completed
- Sponsor
- MannKind
- Start
- Sep 2017
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TI-Inhalation Powder B in type 1 diabetes mellitus (T1D), sponsored by MannKind. Started Sep 2017; status: completed.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02527265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527265.